On June 6, 2016, SGS announced that it will be offering hydrogen deuterium exchange mass spectrometry (HDX MS) capabilities at its West Chester, Pennsylvania facility. This new service, which is currently undergoing installation, will assist in the full characterization of biological molecules,Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.